Cindy Im
,

Credentials

PhD

Assistant Professor, Division of Pediatric Epidemiology & Clinical Research

Faculty, Department of Pediatrics

Co-Chair, Epidemiology/Biostatistics Working Group, Childhood Cancer Survivor Study (CCSS)

Member, Masonic Cancer Center

Member, St. Jude Lifetime Cohort Study (SJLIFE) Genomics/Genetics Working Group

Biography

Bio

Cindy Im, PhD, MPH is an Assistant Professor in the Division of Epidemiology and Clinical Research in the Department of Pediatrics. She engages in multidisciplinary research that combines biological, epidemiological, and data sciences. Research areas of interest include childhood cancer survivorship and late effects risk prediction; racial/ethnic disparities in cancer-related outcomes; and genetic epidemiology/statistical genetics methodology. Her NIH-funded studies include the following:

R01HL173881, Developing and Validating Race-Specific Cardiomyopathy Risk Prediction Models in African American Survivors of Childhood Cancer (MPI: C Im/Y Sapkota)
R01CA283333, Genetic Pleiotropy Across Pediatric Cancers and Cancer-Related Outcomes (MPI: C Im/Z Wang)
R21CA261833, Treatment-specific genetic risk scores for late effects prediction in childhood, adolescent, and young adult cancer survivors (MPI: C Im/Y Yuan)

Education

PhD in Epidemiology, School of Public Health, University of Alberta Edmonton, AB, Canada

MPH, Health Policy & Management, Mailman School of Public Health, Columbia University, New York, NY, USA

BS, Yale University, New Haven, CT, USA

Honors and Recognition

University of Minnesota Pediatric Foundation Scholar

Assistant Professor Clinical/Translational Paper of the Year, Department of Pediatrics, University of Minnesota (2023, 2024)

Selected Publications

Im C, Neupane A, Baedke JL, Delaney A, Dixon SB, Chow EJ, Richard MA, Gramatges MM, Lupo PJ, Sharafeldin N, Bhatia S, Armstrong GT, Hudson MM, Ness KK, Robison LL, Yasui Y, Wilson CL, Sapkota Y. Trans-ancestral genetic risk factors for treatment-related type 2 diabetes mellitus in survivors of childhood cancer. Journal of Clinical Oncology. 2024 [in press; https://doi.org/10.1200/JCO.23.0228].

Im C, Lu Z, Mostoufi-Moab S, Delaney A, Yu L, Baedke JL, Han Y, Sapkota Y, Yasui Y, Chow EJ, Howell RM. Development and validation of age-specific risk prediction models for primary ovarian insufficiency in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study and St Jude Lifetime Cohort. The Lancet Oncology. 2023 Nov 13. PMID: 37972608.

Im C, Sharafeldin N, Yuan Y, Wang Z, Sapkota Y, Lu Z, Spector LG, Howell RM, Arnold MA, Hudson MM, Ness KK, Robison LL, Bhatia S, Armstrong GT, Neglia JP, Yasui Y, Turcotte LM. Polygenic risk and chemotherapy-related subsequent malignancies among long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study and St. Jude Lifetime Cohort Study. Journal of Clinical Oncology. 2023 Sep 20;41(27):4381-93. PMID: 37459583.

Im C, Yuan Y, Austin ED, Stokes DC, Krasin MJ, Davidoff AM, Sapkota Y, Wang Z, Ness KK, Wilson CL, Armstrong GT, Hudson MM, Robison LL, Mulrooney DA, Yasui Y. Leveraging Therapy-Specific Polygenic Risk Scores to Predict Restrictive Lung Defects in Childhood Cancer Survivors. Cancer Res. 2022 Aug 16;82(16):2940-2950.

Im C, Li N, Moon W, Liu Q, Morton LM, Leisenring WM, Howell RM, Chow EJ, Sklar CA, Wilson CL, Wang Z, Sapkota Y, Chemaitilly W, Ness KK, Hudson MM, Robison LL, Bhatia S, Armstrong GT, Yasui Y. Genome-wide association studies reveal novel locus with sex-/therapy-specific fracture risk effects in childhood cancer survivors. J Bone Miner Res. 2021 Apr;36(4):685-695.

Im C, Qin N, Wang Z, Qiu W, Howell CR, Sapkota Y, Moon W, Chemaitilly W, Gibson TM, Mulrooney DA, Ness KK, Wilson CL, Morton LM, Armstrong GT, Bhatia S, Zhang J, Hudson MM, Robison LL, Yasui Y. Generalizability of “GWAS hits” in clinical populations: Lessons from childhood cancer survivors. Amer J Hum Genet. 2020 Oct 1;107(4):636-53.

Contact

Address

D529-3B Mayo
420 Delaware St. SE
Minneapolis, MN 55455